Our partnership with Lilly reflects our resolve to address one of the most pressing health concerns of our time and offer patients innovative, accessible solutions that can transform health outcomes
You purchase supplements to support your health and DRcaps protect the ingredients until they can be fully assimilated by your body - maximizing their benefits.
By mapping these 150+ genetic insights, PlexusDx enables truly precision medicinemoving beyond one-size-fits-all dosing to a strategy tailored to your peptide pathways
This configuration supports precise dosing, reproducibility, and sterile handling in laboratory settings
In the STEP-1 trial, semaglutide 2.4 mg resulted in an approximately 15 percent body weight reduction
PlexusDx supports this journey through ongoing dose optimization, medication adjustments, and periodic genetic testing to ensure the treatment plan evolves with the patient's response